ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Are New Biologics a Game Changer for Treating Nasal Polyposis?

by Susan Bernstein • November 11, 2019

  • Tweet
  • Email
Print-Friendly Version

Surgery is a time-honored treatment with low side effects. If a patient’s symptoms come back, then I would consider biologics. Biologics give us another piece in our armamentarium of treatment. —James N. Palmer, MD

You Might Also Like

  • Biologics for Chronic Rhinosinusitis and Nasal Polyposis
  • Polyp Recurrence Still Common After ESS for CRS with Nasal Polyposis
  • Pre-Operative Steroid Use Beneficial Preceding Nasal Polyposis Surgery
  • Steroid-Eluting Implants Effective for Recurrent Nasal Polyps
Explore This Issue
November 2019

Shared Decision Making

Will otolaryngologists feel threatened by the emergence of biologics that reduce the number of sinus surgeries? This is a natural response, “but also a completely inappropriate way for us to respond to new treatments and technologies that may benefit our patients,” says Dr. Smith. “We have a potential conflict of interest as sinus surgeons. Our allergy/immunology colleagues have a potential conflict of interest as well. The worst thing we can do is put our patients in the middle of our conflicts of interest.”

Dr. Laidlaw, an allergist, said she works in a multidisciplinary manner with surgeons in her health system, so patients are referred to the right clinician for treatment appropriate for their situation.

Dr. Smith agreed. “This highlights the need for multidisciplinary management of this patient population. None of us has all the tools. We need to work together,” he said. “This issue really pushes the paradigm of multidisciplinary collaboration, and that’s where we should take this, almost like tumor boards in cancer treatment. We can make recommendations to patients as a multidisciplinary group.” 


Susan Bernstein is a freelance medical writer based in Georgia.

Key Points

  • Biologics target and suppress specific drivers of inflammation and work well in some patients to treat the symptoms of nasal polyps.
  • Cost and the need for regular injections for an indefinite period of time are two major concerns among otolaryngologists.

Biologics: Inflammatory Targets

Biologics suppress inflammation, so the argument in favor of these drugs is that they will be more effective in patients with poorly controlled, severe nasal asthma and polyps that are inflammation-driven, but there are still many unknowns about these drugs in this patient population, said Dr. Bleier.

“If you have a patient who is struggling with asthma control, has severe polyps, and is a poor surgery candidate, they may be a good biologics candidate. We always have to balance the cost of therapy and the true efficacy of therapy,” he said. “Because these drugs are very new, in addition to unknown efficacy across the general spectrum of patients, we don’t know if there will be a rebound effect, or if there is better efficacy in treatment-refractory patients.”

Dr. Bleier describes polyps as “bags full of inflammatory products,” or cytokines that are targeted by biologics. Once polyps are surgically removed, he wonders if biologics may work better, because “the cytokines are already reduced.”

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Home Slider, Practice Focus, Rhinology Tagged With: biologics, Nasal polyposis, nasal polypsIssue: November 2019

You Might Also Like:

  • Biologics for Chronic Rhinosinusitis and Nasal Polyposis
  • Polyp Recurrence Still Common After ESS for CRS with Nasal Polyposis
  • Pre-Operative Steroid Use Beneficial Preceding Nasal Polyposis Surgery
  • Steroid-Eluting Implants Effective for Recurrent Nasal Polyps

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.